Teijin, Pulmagen enter agreement for asthma drugLicensing Agreement • October 31st, 2022
Contract Type FiledOctober 31st, 2022
Teijin, Pulmagen enter agreement for asthma drugLicensing Agreement • May 28th, 2021
Contract Type FiledMay 28th, 2021
Teijin, Pulmagen enter agreement for asthma drugLicensing Agreement • May 28th, 2021
Contract Type FiledMay 28th, 2021
Teijin, Pulmagen enter agreement for asthma drugLicensing Agreement • May 28th, 2021
Contract Type FiledMay 28th, 2021
Teijin, Pulmagen enter agreement for asthma drugLicensing Agreement • May 28th, 2021
Contract Type FiledMay 28th, 2021
Teijin, Pulmagen enter agreement for asthma drugLicensing Agreement • May 28th, 2021
Contract Type FiledMay 28th, 2021
Teijin, Pulmagen enter agreement for asthma drugLicensing Agreement • May 28th, 2021
Contract Type FiledMay 28th, 2021
Teijin, Pulmagen enter agreement for asthma drugLicensing Agreement • May 28th, 2021
Contract Type FiledMay 28th, 2021
Teijin, Pulmagen enter agreement for asthma drugLicensing Agreement • May 28th, 2021
Contract Type FiledMay 28th, 2021